Dietary fatty acids in the secondary prevention of coronary heart disease: a systematic review, meta-analysis and meta-regression.

PubWeight™: 0.87‹?›

🔗 View Article (PMC 3996809)

Published in BMJ Open on April 19, 2014

Authors

Lukas Schwingshackl1, Georg Hoffmann

Author Affiliations

1: Faculty of Life Sciences, Department of Nutritional Sciences, University of Vienna, Vienna, Austria.

Articles cited by this

Measuring inconsistency in meta-analyses. BMJ (2003) 128.20

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med (2009) 65.36

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ (2008) 33.10

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ (2011) 29.14

Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA (2006) 12.44

GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol (2010) 11.77

Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation (2006) 11.65

Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care (2008) 9.34

Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet (1989) 9.27

Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet (1994) 9.13

Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men. Lancet (1981) 7.05

Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS) Lancet (1992) 7.04

Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr (2003) 6.83

Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet (1990) 6.49

Concern Effect of an Indo-Mediterranean diet on progression of coronary artery disease in high risk patients (Indo-Mediterranean Diet Heart Study): a randomised single-blind trial. Lancet (2002) 6.44

Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr (2009) 5.79

Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am J Clin Nutr (2010) 4.85

A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med (2009) 4.80

Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med (2010) 4.79

AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation (2011) 4.65

Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ (2013) 3.78

The diet and 15-year death rate in the seven countries study. Am J Epidemiol (1986) 3.69

Dietary fat intake and prevention of cardiovascular disease: systematic review. BMJ (2001) 3.29

Concern Randomised controlled trial of cardioprotective diet in patients with recent acute myocardial infarction: results of one year follow up. BMJ (1992) 3.14

Quantitative effects of dietary fat on serum cholesterol in man. Am J Clin Nutr (1965) 3.00

Suspected research fraud: difficulties of getting at the truth. BMJ (2005) 2.61

Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP). Circulation (1994) 2.50

Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database Syst Rev (2012) 2.47

CORN OIL IN TREATMENT OF ISCHAEMIC HEART DISEASE. Br Med J (1965) 2.37

The Oslo diet-heart study. Eleven-year report. Circulation (1970) 2.10

Low fat, low cholesterol diet in secondary prevention of coronary heart disease. Adv Exp Med Biol (1978) 2.05

Expression of concern: Indo-Mediterranean Diet Heart Study. Lancet (2005) 1.93

Mediterranean diet has no effect on markers of inflammation and metabolic risk factors in patients with coronary artery disease. Eur J Clin Nutr (2006) 1.73

Comparison of low-fat versus Mediterranean-style dietary intervention after first myocardial infarction (from The Heart Institute of Spokane Diet Intervention and Evaluation Trial). Am J Cardiol (2008) 1.61

Reduction in sudden deaths by a multifactorial intervention programme after acute myocardial infarction. Lancet (1979) 1.60

Fats and fatty acids in human nutrition. Report of an expert consultation. FAO Food Nutr Pap (2010) 1.57

The relation in man between cholesterol levels in the diet and in the blood. Science (1950) 1.48

Dietary fat and coronary heart disease: summary of evidence from prospective cohort and randomised controlled trials. Ann Nutr Metab (2009) 1.36

Controlled trial of soya-bean oil in myocardial infarction. Lancet (1968) 1.35

Low-fat diet in myocardial infarction: A controlled trial. Lancet (1965) 1.29

Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database Syst Rev (2001) 1.08

Monounsaturated fatty acids and risk of cardiovascular disease: synopsis of the evidence available from systematic reviews and meta-analyses. Nutrients (2012) 1.07

The National Diet-Heart Study Final Report. Circulation (1968) 0.91

Review of dietary intervention studies: effect on coronary events and on total mortality. Aust N Z J Med (1994) 0.85

The 5-year experience of modified fat diets on younger men with coronary heart disease. Circulation (1970) 0.83

Effect of dietary intervention and lipid-lowering treatment on brachial vasoreactivity in patients with ischemic heart disease and hypercholesterolemia. Am Heart J (2003) 0.81

Predictive value of lipid profile for salutary coronary angiographic changes in patients on a low-fat diet and physical exercise program. Am J Cardiol (1996) 0.81

Low-fat diet and regular, supervised physical exercise in patients with symptomatic coronary artery disease: reduction of stress-induced myocardial ischemia. Circulation (1988) 0.81

Articles by these authors

Adherence to Mediterranean diet and risk of cancer: a systematic review and meta-analysis of observational studies. Int J Cancer (2014) 1.54

Diet quality as assessed by the Healthy Eating Index, the Alternate Healthy Eating Index, the Dietary Approaches to Stop Hypertension score, and health outcomes: a systematic review and meta-analysis of cohort studies. J Acad Nutr Diet (2015) 1.44

Inducible nitric oxide synthase--time for reappraisal. Curr Drug Targets Inflamm Allergy (2002) 1.07

Monounsaturated fatty acids and risk of cardiovascular disease: synopsis of the evidence available from systematic reviews and meta-analyses. Nutrients (2012) 1.07

Long-term effects of low-fat diets either low or high in protein on cardiovascular and metabolic risk factors: a systematic review and meta-analysis. Nutr J (2013) 1.06

Comparison of effects of long-term low-fat vs high-fat diets on blood lipid levels in overweight or obese patients: a systematic review and meta-analysis. J Acad Nutr Diet (2013) 0.95

Monounsaturated fatty acids, olive oil and health status: a systematic review and meta-analysis of cohort studies. Lipids Health Dis (2014) 0.92

Impact of different training modalities on glycaemic control and blood lipids in patients with type 2 diabetes: a systematic review and network meta-analysis. Diabetologia (2014) 0.90

Impact of long-term lifestyle programmes on weight loss and cardiovascular risk factors in overweight/obese participants: a systematic review and network meta-analysis. Syst Rev (2014) 0.89

Clinical and biochemical characterization of patients with early infantile onset of autosomal recessive GTP cyclohydrolase I deficiency without hyperphenylalaninemia. Mov Disord (2010) 0.88

Association of dietary, circulating, and supplement fatty acids with coronary risk. Ann Intern Med (2014) 0.83

Acute injury risk and severity in indoor climbing-a prospective analysis of 515,337 indoor climbing wall visits in 5 years. Wilderness Environ Med (2013) 0.81

Detection and documentation of DRG-relevant comorbidities using laboratory tests. Aust Health Rev (2002) 0.80

[Interaction of hypoxia and haemostasis--hypoxia as a prothrombotic factor at high altitude?]. Wien Med Wochenschr (2005) 0.77

Low-carbohydrate diets impair flow-mediated dilatation: evidence from a systematic review and meta-analysis. Br J Nutr (2013) 0.77

Moscow theatre siege and anaesthetic drugs. Lancet (2003) 0.77

Circadian variation on oxygen consumption in preterm infants. J Perinat Med (2009) 0.76

An Umbrella Review of Nuts Intake And Risk of Cardiovascualr Disease. Curr Pharm Des (2016) 0.76

Increased GTP cyclohydrolase activity promotes tumor growth. Int J Cancer (2012) 0.75

Neopterin as a potential modulator of tumor cell growth and proliferation. Med Hypotheses (2003) 0.75

Improving quality in the preanalytical phase through innovation, on behalf of the European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for Preanalytical Phase (WG-PRE). Clin Chem Lab Med (2017) 0.75

The ongoing need for innovation in transplant medicine and surgery. Transplantation (2005) 0.75